Stereotaxis Inc (STXS) - Total Assets
Based on the latest financial reports, Stereotaxis Inc (STXS) holds total assets worth $45.59 Million USD as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Stereotaxis Inc - Total Assets Trend (2000–2024)
This chart illustrates how Stereotaxis Inc's total assets have evolved over time, based on quarterly financial data. Also see Stereotaxis Inc market capitalisation for the company's overall valuation and market capitalisation.
Stereotaxis Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
Stereotaxis Inc's total assets of $45.59 Million consist of 56.6% current assets and 43.4% non-current assets. Review STXS liabilities breakdown to assess the company's total debt and financial obligations.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 26.2% |
| Accounts Receivable | $3.82 Million | 8.2% |
| Inventory | $8.33 Million | 17.8% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $7.36 Million | 15.8% |
| Goodwill | $3.76 Million | 8.1% |
Asset Composition Trend (2000–2024)
This chart illustrates how Stereotaxis Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See today's stock price for Stereotaxis Inc for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Stereotaxis Inc's current assets represent 56.6% of total assets in 2024, an increase from 0.0% in 2000.
- Cash Position: Cash and equivalents constituted 26.2% of total assets in 2024, up from 0.0% in 2000.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 23.0% of total assets, an increase from 0.0% in 2000.
- Asset Diversification: The largest asset category is inventory at 17.8% of total assets.
Stereotaxis Inc Competitors by Total Assets
Key competitors of Stereotaxis Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Gan & Lee Pharmaceuticals Co Ltd
SHG:603087
|
China | CN¥12.68 Billion |
|
Andon Health Co Ltd
SHE:002432
|
China | CN¥29.91 Billion |
|
Shenyang Xingqi Pharmaceutical Co Ltd
SHE:300573
|
China | CN¥2.42 Billion |
|
Pegavision
TW:6491
|
Taiwan | NT$16.17 Billion |
|
Nanosonics Ltd
AU:NAN
|
Australia | AU$279.25 Million |
|
Visco Vision Inc.
TW:6782
|
Taiwan | NT$5.82 Billion |
|
QITIAN Technology Group Co Ltd
SHE:300061
|
China | CN¥1.17 Billion |
|
Embecta Corp
NASDAQ:EMBC
|
USA | $1.27 Billion |
Stereotaxis Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.31 | 1.39 | 3.88 |
| Quick Ratio | 0.81 | 0.96 | 3.64 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $6.29 Million | $8.09 Million | $39.14 Million |
Stereotaxis Inc - Advanced Valuation Insights
This section examines the relationship between Stereotaxis Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 30.09 |
| Latest Market Cap to Assets Ratio | 3.83 |
| Asset Growth Rate (YoY) | 11.5% |
| Total Assets | $46.72 Million |
| Market Capitalization | $179.18 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Stereotaxis Inc's assets at a significant premium (3.83x), suggesting investors see substantial growth potential or unique competitive advantages.
Rapid Asset Growth: Stereotaxis Inc's assets grew by 11.5% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Stereotaxis Inc (2000–2024)
The table below shows the annual total assets of Stereotaxis Inc from 2000 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $46.72 Million | +11.49% |
| 2023-12-31 | $41.91 Million | -21.54% |
| 2022-12-31 | $53.41 Million | -12.42% |
| 2021-12-31 | $60.98 Million | +9.97% |
| 2020-12-31 | $55.46 Million | +27.24% |
| 2019-12-31 | $43.58 Million | +135.41% |
| 2018-12-31 | $18.51 Million | +73.57% |
| 2017-12-31 | $10.67 Million | -49.12% |
| 2016-12-31 | $20.97 Million | +9.04% |
| 2015-12-31 | $19.23 Million | -19.49% |
| 2014-12-31 | $23.88 Million | -23.15% |
| 2013-12-31 | $31.08 Million | -3.39% |
| 2012-12-31 | $32.17 Million | -19.45% |
| 2011-12-31 | $39.93 Million | -39.28% |
| 2010-12-31 | $65.76 Million | +17.18% |
| 2009-12-31 | $56.12 Million | -5.59% |
| 2008-12-31 | $59.44 Million | -1.71% |
| 2007-12-31 | $60.48 Million | -12.72% |
| 2006-12-31 | $69.29 Million | +89.02% |
| 2005-12-31 | $36.66 Million | -48.50% |
| 2004-12-31 | $71.19 Million | +90.73% |
| 2003-12-31 | $37.32 Million | +13.37% |
| 2002-12-31 | $32.92 Million | +30.79% |
| 2000-12-31 | $25.17 Million | -- |
About Stereotaxis Inc
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. The company offers robotic magnetic navigation (RMN) systems, such as the Genesis RMN, which enable physicians to complete interventional procedures by providing image-guided delivery of catheters and guidewires thro… Read more